Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 3 of the 173 sources its claims cite were checked for support.

In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.

Open access
Hotterbeekx, An, Kumar-Singh, Samir, Goossens, Herman, Malhotra-Kumar, Surbhi · 2017 · Frontiers in Cellular and Infection Microbiology

Abstract

The significance of polymicrobial infections is increasingly being recognized especially in a biofilm context wherein multiple bacterial species – including both potential pathogens and members of the commensal flora – communicate, cooperate and compete with each other. Two important bacterial pathogens that have developed a complex network of evasion, counter-inhibition and subjugation in their battle for space and nutrients are Pseudomonas aeruginosa and Staphylococcus aureus. Their strain- and environment-specific interactions, for instance in the cystic fibrosis lung or in wound infections, show severe competition that is generally linked to worse patient outcomes. For instance, the extracellular factors secreted by P. aeruginosa have been shown to subjugate S. aureus to persist as small colony variants. On the other hand, data also exist where S. aureus inhibits biofilm formation by P. aeruginosa but also protects the pathogen by inhibiting its phagocytosis. Interestingly, such interspecies interactions differ between the planktonic and biofilm phenotype, with the extracellular matrix components of the latter likely being a key, and largely underexplored, influence.This review attempts to understand the complex relationship between P. aeruginosa and Staphylococcus spp., focusing on S. aureus, that not only is interesting from the bacterial evolution point of view, but also has important consequences for our understanding of the disease pathogenesis for better patient management.

Overview

CoChat Summary

TL;DR

This review synthesizes in vivo and in vitro evidence on interactions between Pseudomonas aeruginosa and Staphylococcus spp., focusing on S. aureus, in biofilm and planktonic contexts. It describes a balance between P. aeruginosa antagonism—often via quorum-sensing-regulated factors such as HQNO, pyocyanin, LasA, rhamnolipids, and AHLs—and S. aureus survival strategies including SCV formation, SpA binding, and quorum quenching, with co-infection generally linked to worse outcomes.

Key findings

  • Co-occurrence of P. aeruginosa and S. aureus in CF and chronic wounds is linked to worse outcomes: additive disease severity and increased lung inflammation/damage; MRSA is associated with worse lung function only in combination with P. aeruginosa. In a rabbit ear wound model, mixed infection increased IL-1β and TNF-α and reached equilibrium after 12 days with P. aeruginosa dominant; in a mouse chronic wound model, a four-species biofilm delayed healing only at 8 days post-infection and showed increased antimicrobial tolerance.
  • P. aeruginosa produces multiple anti-staphylococcal molecules: HQNO and pyocyanin inhibit oxidative respiration and select for the SCV phenotype; LasA protease/staphylolysin lyses S. aureus; rhamnolipids and cis-2-decenoic acid induce biofilm dispersal and inhibit adhesion; long-chain AHLs (C8–C14, with C12 and C14 most effective) inhibit S. aureus growth and reduce sarA/agr function.
  • S. aureus counter-strategies include the SigB-dependent SCV switch, which increases aminoglycoside resistance, biofilm formation, and intracellular survival; secreted protein A (SpA) binds Psl and type IV pili and protects P. aeruginosa from phagocytosis; yayurea A and B from the S. intermedius group quorum-quench Gram-negative bacteria; and CydAB variants in non-pathogenic staphylococci confer resistance to pyocyanin.
  • Host/commensal molecules modulate virulence: AI-2 upregulates P. aeruginosa lasB, rhlA, exoT/exoS/exoY, and phzA1/phzA2; GlcNAc enhances PQS and virulence; D-ribose treatment significantly decreased biomass and lowered rat mortality in a dual-species ventilation model.

Methods

  • Narrative review; no primary experiments. It synthesizes in vivo human/animal observations and in vitro studies on P. aeruginosa and Staphylococcus spp., primarily S. aureus.
  • Main analysis is a qualitative synthesis of cited literature, organized by in vivo outcomes, P. aeruginosa virulence factors, S. aureus survival/SCV biology, dual-species biofilms, and other staphylococci. No systematic search, meta-analysis, or primary sample is described.

Limitations

  • The paper states that interactions are strain- and environment-specific, that extracellular matrix components are largely underexplored, and that discrepancies between studies (e.g., Psl/S. aureus co-culture results, pigment production) indicate the importance of co-evolution and adaptation; further studies are awaited.
  • Evident from the text: as a narrative review, it lacks a described systematic search or quality appraisal and relies on heterogeneous models, strains, and conditions, limiting generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fcimb.2017.00106

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Interactions in the cystic fibrosis lung. The complex interplay between microbial competition and the human immune system results in increased secretion of pro-inflammatory cytokines, microbial virulence factors and consequently tissue damage and bacterial invasion of the epithelial barrier. Mixed species infections lead to a stronger decrease in ciliary beating and increased goblet cell hyperplasia and tissue fibrosis, which are characteristic of cystic fibrosis disease progression. PQS, Pseudomonas quinolone signal; T3SS, type 3 secretion system; AI-2, autoinducer 2.
Figure 1 Interactions in the cystic fibrosis lung. The complex interplay between microbial competition and the human immune system results in increased secretion of pro-inflammatory cytokines, microbial virulence factors and consequently tissue damage and bacterial invasion of the epithelial barrier. Mixed species infections lead to a stronger decrease in ciliary beating and increased goblet cell hyperplasia and tissue fibrosis, which are characteristic of cystic fibrosis disease progression. PQS, Pseudomonas quinolone signal; T3SS, type 3 secretion system; AI-2, autoinducer 2.CC BY · PubMed Central
Figure 2 Small molecules secreted by P. aeruginosa and S. aureus. Extracellular factors produced by P. aeruginosa affect biofilm formation, oxidative respiration, cell lysis and virulence of S. aureus. Lysis of S. aureus leads to increased extracellular iron and N-acetyl glucosamine (GlcNac), which are sensed by P. aeruginosa. AHL, N-acyl homoserine lactone; HQNO, 4-hydroxy-2-heptylquinoline N-oxide; PQS, Pseudomonas quinolone signal; GlcNac, N-acetyl glucosamine.
Figure 2 Small molecules secreted by P. aeruginosa and S. aureus. Extracellular factors produced by P. aeruginosa affect biofilm formation, oxidative respiration, cell lysis and virulence of S. aureus. Lysis of S. aureus leads to increased extracellular iron and N-acetyl glucosamine (GlcNac), which are sensed by P. aeruginosa. AHL, N-acyl homoserine lactone; HQNO, 4-hydroxy-2-heptylquinoline N-oxide; PQS, Pseudomonas quinolone signal; GlcNac, N-acetyl glucosamine.CC BY · PubMed Central
Figure 3 Interactions in mixed species biofilms. Differences in biofilm formation by S. aureus with a Psl- or Pel-dominant P. aeruginosa strain. IgG, immunoglobulin G.
Figure 3 Interactions in mixed species biofilms. Differences in biofilm formation by S. aureus with a Psl- or Pel-dominant P. aeruginosa strain. IgG, immunoglobulin G.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 127 Not checked · 30 Own results and interpretations

79 more claims

Create a free account to see all 159 claims and to verify the 164 references still open.

See all claims — free account
  • It may state two separate claims as one. 70
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Citations

Cites

Cited by

See all 289

Metadata

Authors
Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S.
Affiliations
University of Antwerp (BE)
Venue
Frontiers in Cellular and Infection Microbiology
Published
2017-04-03
Volume
7
Pages
106-106
ISSN
2235-2988 (ISSN-L)
OpenAlex
W2599504373
Cited by
289
References
85
Citations by year
2026: 28 · 2025: 29 · 2024: 31 · 2023: 39 · 2022: 44 · 2021: 41 · 2020: 35 · 2019: 23 · 2018: 19
FWCI
1.91
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
  • Fonds Wetenschappelijk Onderzoek (G.0513.12)
  • IMI (115737-2)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
Keywords
Pseudomonas aeruginosa, Staphylococcus aureus, interspecies interactions, co-infection, biofilm, small colony variants, phagocytosis inhibition, extracellular matrix, cystic fibrosis lung infection, wound infection, bacterial competition, commensal microbiota
MeSH terms
Animals, Disease Models, Animal, Humans, Pseudomonas aeruginosa, Staphylococcus aureus, Microbial Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.